共 39 条
- [32] Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL) LANCET INFECTIOUS DISEASES, 2016, 16 (04): : 421 - 430
- [36] Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial LANCET RESPIRATORY MEDICINE, 2019, 7 (09): : 791 - 801
- [37] Re: Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial. Cooper C, Reginster JY, Chapurlat R, et al. Curr Med Res Opin 2012;28:231-9. CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (04) : 609 - 609
- [38] Duvakitug (TEV-48574), an anti-TL1a monoclonal antibody, demonstrates efficacy and favourable safety as an induction treatment in adults with moderately to severely active Crohn's disease: results from a phase 2b, randomised, double-blind, placebo-controlled dose-ranging, basket trial (RELIEVE UCCD) JOURNAL OF CROHNS & COLITIS, 2025, 19 : i77 - i78
- [39] Duvakitug (TEV-48574), an anti-TL1a monoclonal antibody, demonstrates efficacy and favourable safety as an induction treatment in adults with moderately to severely active ulcerative colitis: Results from a phase 2b, randomised, double-blind, placebo-controlled, dose-ranging, basket trial (RELIEVE UCCD) JOURNAL OF CROHNS & COLITIS, 2025, 19 : i79 - i80